EKSO BIONICS HOLDINGS, INC. — Director's Dealing 2017

Sep 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EKSO BIONICS HOLDINGS, INC. (EKSO)
CIK: 0001549084
Period of Report: 2017-08-31

Reporting Person: Looby Thomas (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-31	Common Stock	X	3714	$1.00	Acquired	5315	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-31	Subscription Rights (right to buy)	$1.00	X	1601	Disposed	2017-08-31	Common Stock (3714)	Direct

Footnotes

F1: On August 14, 2017, Ekso Bionics Holdings, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock and certain holders of warrants issued by the Company, as of the record date of August 10, 2017, to subscribe for up to an aggregate of 34,000,000 shares of common stock. Each subscription right included a basic subscription right, which entitled its holder to purchase 1.1608 shares of common stock at a subscription price of $1.00, and an over-subscription right, which entitled its holder to purchase up to 1.1608 shares of common stock at a subscription price of $1.00, subject to the availability and pro rata allocation of shares among rights holders exercising their over-subscription rights.

F2: The reporting person exercised in full his basic subscription rights, pursuant to which he acquired 1,857 shares of common stock. The reporting person also exercised in full his over-subscription rights for an additional 1,857 shares of common stock.